课题基金 / 基金详情

Modulators of Secreted ER Ca2+ Monitoring Protein (SERCaMP)

Modulators of Secreted ER Ca2+ Monitoring Protein (SERCaMP)
分泌型 ER Ca2 监测蛋白 (SERCaMP) 调节剂
批准号:
9205622
负责人:
Ajit Jadhav
金额:
$1.9万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Ajit Jadhav的其他基金

相似基金

相关文献

中文摘要
翻译
在此期间,NCGC与NIH和校外研究人员建立并维持了180多项积极合作,促进了整个人类疾病范围内的药物发现工作。这些努力已经导致了100多个高通量筛选和近60个药物化学活动,为我们的合作者和一般研究界提供了丰富的出版物和有前途的小分子线索。此外,NCGC还承担了一些信息学方面的挑战,以便更好地利用现有的药物和疾病目标信息,并向公众提供易于获得的资源,进一步促进人类疾病新疗法的发展。
英文摘要
During this period, the NCGC has fostered and maintained over 180 active collaborations with both NIH and extramural investigators, facilitating drug discovery efforts across the entire spectrum of human disease. These efforts have led to over 100 high-throughput screens and nearly 60 medicinal chemistry campaigns, providing our collaborators and the general research community a wealth of publications and promising small molecule leads. In addition, the NCGC has undertaken a number of informatic challenges to make better use of existing drug and disease target information and provide the general public with easily accessible resources, further catalyzing the development of new therapies for human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Irreversible targeting of mammalian thioredoxin reductase 1 (TrxR1) for anticancer therapy
Phenotypic Screening to Identify Regulators of CFTR Localization
Selective inhibitors of citron rho kinase (CIT-K)
Selective inhibitors of citron rho kinase (CIT-K)
海外基金